Tag: translating research
Professor Allan Bradley, former Director of the Wellcome Sanger Institute and entrepreneur behind Lexicon Pharmaceuticals, Kymab, and T-Therapeutics among others, was invited to speak at the EpiCrossBorders Symposium hosted by the Institute of Genetics and Cancer. EpiCrossBorders is a collaborative PhD programme between Helmholtz Munch and The University of Edinburgh covering a broad range of […]